Complement Depletion Deteriorates Clinical Outcomes of Severe Abdominal Sepsis: A Conspirator of Infection and Coagulopathy in Crime?

PLoS ONE

Volumn 7, Issue 10, 2012, Pages

  Ren, Jianan ^a   Zhao, Yunzhao ^a   Yuan, Yujie ^a   Han, Gang ^a   Li, Weiqin ^a   Huang, Qian ^a   Tong, Zhihui ^a   Li, Jieshou ^a  

^a MEDICAL SCHOOL OF NANJING UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

C REACTIVE PROTEIN; COMPLEMENT COMPONENT C3A; COMPLEMENT COMPONENT C4A; COMPLEMENT COMPONENT C5A; D DIMER;

ARTICLE; BLOOD CLOTTING DISORDER; CLINICAL ARTICLE; COHORT ANALYSIS; COMPLEMENT SYSTEM; DISEASE SEVERITY; HUMAN; INCIDENCE; LENGTH OF STAY; MORTALITY; PILOT STUDY; POSTOPERATIVE COMPLICATION; PREDICTION; PROGNOSIS; PROSPECTIVE STUDY; RECEIVER OPERATING CHARACTERISTIC; RISK FACTOR; SCORING SYSTEM; SEPSIS;

ADULT; BLOOD COAGULATION; BLOOD COAGULATION DISORDERS; COMPLEMENT C3; COMPLEMENT SYSTEM PROTEINS; FEMALE; FISTULA; HUMANS; INTRAABDOMINAL INFECTIONS; MALE; MIDDLE AGED; PROGNOSIS; PROSPECTIVE STUDIES; ROC CURVE; SEPSIS; SEVERITY OF ILLNESS INDEX;

EID: 84867585948     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0047095     Document Type: Article

References (38)

1. Martinez JL, Luque-de-Leon E, Ballinas-Oseguera G, Mendez JD, Juarez-Oropeza MA, et al. (2012) Factors predictive of recurrence and mortality after surgical repair of enterocutaneous fistula. J Gastrointest Surg 16: 156-163; discussion 163-154.
2. Ward PA, Gao H, (2009) Sepsis, complement and the dysregulated inflammatory response. J Cell Mol Med 13: 4154-4160.
3. Yalcindag A, He R, Laouini D, Alenius H, Carroll M, et al. (2006) The complement component C3 plays a critical role in both Th1 and Th2 responses to antigen. J Allergy Clin Immunol 117: 1455-1461.
4. Leendertse M, Willems RJ, Flierman R, de Vos AF, Bonten MJ, et al. (2010) The complement system facilitates clearance of Enterococcus faecium during murine peritonitis. J Infect Dis 201: 544-552.
5. Lambris JD, Hajishengallis G, (2012) Innate immunity mechanisms. Adv Exp Med Biol 946: v.
6. Semeraro N, Ammollo CT, Semeraro F, Colucci M, (2012) Sepsis, thrombosis and organ dysfunction. Thromb Res 129: 290-295.
7. Amara U, Flierl MA, Rittirsch D, Klos A, Chen H, et al. (2010) Molecular intercommunication between the complement and coagulation systems. J Immunol 185: 5628-5636.
8. Dellinger RP, Levy MM, Carlet JM, Bion J, Parker MM, et al. (2008) Surviving Sepsis Campaign: international guidelines for management of severe sepsis and septic shock: 2008. Crit Care Med 36: 296-327.
9. Bee TK, Croce MA, Magnotti LJ, Zarzaur BL, Maish GO 3rd, et al. (2008) Temporary abdominal closure techniques: a prospective randomized trial comparing polyglactin 910 mesh and vacuum-assisted closure. J Trauma 65: 337-342; discussion 342-334.
10. Bearfield P, Agarwal B, Ward S, Martin D, Shaw S, (2010) An audit of timing of tracheostomy formation in neurosurgical patients: how long should we wait? Critical Care 14: P223.
11. Chapman R, Foran R, Dunphy JE, (1964) Management of Intestinal Fistulas. Am J Surg 108: 157-164.
12. Jones AE, Trzeciak S, Kline JA, (2009) The Sequential Organ Failure Assessment score for predicting outcome in patients with severe sepsis and evidence of hypoperfusion at the time of emergency department presentation. Crit Care Med 37: 1649-1654.
13. Delibegovic S, Markovic D, Hodzic S, (2011) APACHE II scoring system is superior in the prediction of the outcome in critically ill patients with perforative peritonitis. Med Arh 65: 82-85.
14. Taylor R, (2007) Fresh frozen plasma as a complement source. Lancet Oncol 8: 370-371.
15. Lin RY, Astiz ME, Saxon JC, Saha DC, Rackow EC, (1993) Alterations in C3, C4, factor B, and related metabolites in septic shock. Clin Immunol Immunopathol 69: 136-142.
16. Peng Z, Singbartl K, Simon P, Rimmele T, Bishop J, et al. (2010) Blood purification in sepsis: a new paradigm. Contrib Nephrol 165: 322-328.
17. Iakovleva II, Timokhov VS, Lialikova GV, Semenov VN, Moroz VV, (1999) [Complement system during hemofiltration in patients with multiple organ failure]. Anesteziol Reanimatol pp. 23-26.
18. Silvester W, (1997) Mediator removal with CRRT: complement and cytokines. Am J Kidney Dis 30: S38-43.
19. Markiewski MM, Nilsson B, Ekdahl KN, Mollnes TE, Lambris JD, (2007) Complement and coagulation: strangers or partners in crime? Trends Immunol 28: 184-192.
20. Silasi-Mansat R, Zhu H, Popescu NI, Peer G, Sfyroera G, et al. (2010) Complement inhibition decreases the procoagulant response and confers organ protection in a baboon model of Escherichia coli sepsis. Blood 116: 1002-1010.
21. Ehrnthaller C, Ignatius A, Gebhard F, Huber-Lang M, (2011) New insights of an old defense system: structure, function, and clinical relevance of the complement system. Mol Med 17: 317-329.
22. Oikonomopoulou K, Ricklin D, Ward PA, Lambris JD, (2012) Interactions between coagulation and complement-their role in inflammation. Semin Immunopathol 34: 151-165.
23. Younger JG, Bracho DO, Chung-Esaki HM, Lee M, Rana GK, et al. (2010) Complement activation in emergency department patients with severe sepsis. Acad Emerg Med 17: 353-359.
24. Wolbink GJ, Bossink AW, Groeneveld AB, de Groot MC, Thijs LG, et al. (1998) Complement activation in patients with sepsis is in part mediated by C-reactive protein. J Infect Dis 177: 81-87.
25. Kupreishvili K, Baidoshvili A, ter Weeme M, Huybregts MA, Krijnen PA, et al. (2011) Degeneration and atherosclerosis inducing increased deposition of type IIA secretory phospholipase A2, C-reactive protein and complement in aortic valves cause neutrophilic granulocyte influx. J Heart Valve Dis 20: 29-36.
26. Yuan SM, Shi YH, Wang JJ, Lu FQ, Gao S, (2011) Elevated plasma D-dimer and hypersensitive C-reactive protein levels may indicate aortic disorders. Rev Bras Cir Cardiovasc 26: 573-581.
27. Ke L, Ni HB, Tong ZH, Li WQ, Li N, et al. (2012) D:-dimer as a marker of severity in patients with severe acute pancreatitis. J Hepatobiliary Pancreat Sci 19: 259-265.
28. Kulkarni SV, Naik AS, Subramanian N Jr, (2007) APACHE-II scoring system in perforative peritonitis. Am J Surg 194: 549-552.
29. Zimmerman JE, Knaus WA, Judson JA, Havill JH, Trubuhovich RV, et al. (1988) Patient selection for intensive care: a comparison of New Zealand and United States hospitals. Crit Care Med 16: 318-326.
30. Sirio CA, Tajimi K, Tase C, Knaus WA, Wagner DP, et al. (1992) An initial comparison of intensive care in Japan and the United States. Crit Care Med 20: 1207-1215.
31. Oh TE, Hutchinson R, Short S, Buckley T, Lin E, et al. (1993) Verification of the Acute Physiology and Chronic Health Evaluation scoring system in a Hong Kong intensive care unit. Crit Care Med 21: 698-705.
32. Wong DT, Crofts SL, Gomez M, McGuire GP, Byrick RJ, (1995) Evaluation of predictive ability of APACHE II system and hospital outcome in Canadian intensive care unit patients. Crit Care Med 23: 1177-1183.
33. Yuan Y, Ren J, Cao S, Zhang W, Li J, (2012) Exogenous C3 protein enhances the adaptive immune response to polymicrobial sepsis through down-regulation of regulatory T cells. Int Immunopharmacol 12: 271-277.
34. Selberg O, Hecker H, Martin M, Klos A, Bautsch W, et al. (2000) Discrimination of sepsis and systemic inflammatory response syndrome by determination of circulating plasma concentrations of procalcitonin, protein complement 3a, and interleukin-6. Crit Care Med 28: 2793-2798.
35. Assicot M, Gendrel D, Carsin H, Raymond J, Guilbaud J, et al. (1993) High serum procalcitonin concentrations in patients with sepsis and infection. Lancet 341: 515-518.
36. Yealy DM, Fine MJ, (2009) Measurement of serum procalcitonin: a step closer to tailored care for respiratory infections? JAMA 302: 1115-1116.
37. Muller B, White JC, Nylen ES, Snider RH, Becker KL, et al. (2001) Ubiquitous expression of the calcitonin-i gene in multiple tissues in response to sepsis. J Clin Endocrinol Metab 86: 396-404.
38. Yuan Y, Ren J, Wu X, Cao S, Li J, (2011) Exogenous C3 postpones complement exhaustion and confers organ protection in murine sepsis. J Surg Res 168: e87-94.